Filing Details

Accession Number:
0001209191-12-046827
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-27 16:29:47
Reporting Period:
2012-09-25
Filing Date:
2012-09-27
Accepted Time:
2012-09-27 16:29:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235007 Endocyte Inc ECYT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509420 D Chandra Lovejoy 3000 Kent Ave, Suite A1-100
West Lafayette IN 47906
Vp Of Regulatory Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-09-25 2,209 $2.54 2,209 No 4 M Direct
Common Stock Disposition 2012-09-25 2,209 $10.28 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2012-09-25 2,209 $0.00 2,209 $2.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,921 2019-03-05 No 4 M Direct
Footnotes
  1. The shares were sold pursuant to a written plan as specified in Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.23 to $10.31, inclusive. The reporting person unertakes to provide Endocyte, Inc., any security holders of Endocyte, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Shares subject to vest monthly over a period of 48 months beginning on March 31, 2009.